| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8791315 | Archivos de la Sociedad Española de Oftalmología | 2017 | 4 Pages |
Abstract
Interferon alpha-2b has been used at conjunctival level as a topical immunomodulator treatment, with complete remission of epithelial neoplasms being observed. However, there have not been any previous publications on the use of interferon alpha-2a, which differs from interferon alpha-2b in a single amino acid, for the treatment of conjunctival squamous cell carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
D. Cruzado-Sánchez, M. Salas-Diaz, W.A. Tellez, S.E. Alvarez-Matos, S. Serpa-FrÃas,